{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:55:09Z","timestamp":1716000909075},"reference-count":33,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"Mapi Research Trust, Lyon,"},{"name":"Bill and Melinda Gates Foundation\u2018s Global Health Travel"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.2217\/imt.09.25","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:20:20Z","timestamp":1630614020000},"page":"549-556","source":"Crossref","is-referenced-by-count":10,"title":["Enhancement of Efficacy of Tuberculosis Drugs With Immunoxel (Dzherelo\u2122) in HIV-Infected Patients With Active Pulmonary Tuberculosis"],"prefix":"10.1080","volume":"1","author":[{"given":"Olga V","family":"Arjanova","sequence":"first","affiliation":[{"name":"Lisichansk Regional Tuberculosis Dispensary, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia D","family":"Prihoda","sequence":"additional","affiliation":[{"name":"Lisichansk Regional Tuberculosis Dispensary, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa V","family":"Yurchenko","sequence":"additional","affiliation":[{"name":"Lisichansk Regional Tuberculosis Dispensary, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina I","family":"Sokolenko","sequence":"additional","affiliation":[{"name":"Lisichansk Regional Tuberculosis Dispensary, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyudmila A","family":"Vihrova","sequence":"additional","affiliation":[{"name":"Lisichansk Regional Hospital, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volodymyr S","family":"Pylypchuk","sequence":"additional","affiliation":[{"name":"Ekomed LLC, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery M","family":"Frolov","sequence":"additional","affiliation":[{"name":"Luhansk Regional AIDS Center, 50-years of Defense of Luhansk street, Luhansk91045, Ukraine."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galyna A","family":"Kutsyna","sequence":"additional","affiliation":[{"name":"Luhansk Regional AIDS Center, 50-years of Defense of Luhansk street, Luhansk91045, Ukraine."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1704"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462053888790"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01583.x"},{"key":"e_1_3_3_3_4_1","first-page":"55","article-title":"Pulmonary tuberculosis and acquired immunodeficiency syndrome in Ukraine (first communication).","volume":"4","author":"Feshchenko II","year":"1997","unstructured":"Feshchenko II , PoddubnyiAF, KunichkinaSA, AntoniakSM: Pulmonary tuberculosis and acquired immunodeficiency syndrome in Ukraine (first communication).Probl. Tuberk.4 , 55\u201357 (1997).","journal-title":"Probl. Tuberk."},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1205.051103"},{"key":"e_1_3_3_3_6_1","first-page":"34","article-title":"Effectiveness of phytoconcentrate Dzherelo\u2122 on immune rehabilitation of patients with erysipiloid pustulous\u2013necrotic complications.","volume":"53","author":"Zeleniy II","year":"2003","unstructured":"Zeleniy II : Effectiveness of phytoconcentrate Dzherelo\u2122 on immune rehabilitation of patients with erysipiloid pustulous\u2013necrotic complications.Probl. Ecol. Med. Gen. Clin. Immun.53 , 34\u201349 (2003).","journal-title":"Probl. Ecol. Med. Gen. Clin. Immun."},{"key":"e_1_3_3_3_7_1","first-page":"92","article-title":"Influence of plant derivative drug Dzherelo\u2122 on cellular immunity among patients with chronically persistent herpetic infection with chronic fatigue syndrome.","volume":"53","author":"Chkhetiany RB","year":"2003","unstructured":"Chkhetiany RB : Influence of plant derivative drug Dzherelo\u2122 on cellular immunity among patients with chronically persistent herpetic infection with chronic fatigue syndrome.Probl. Ecol. Med. Gen. Clin. Immun.53 , 92\u201399 (2003).","journal-title":"Probl. Ecol. Med. Gen. Clin. Immun."},{"key":"e_1_3_3_3_8_1","first-page":"135","article-title":"Influence of plant derivative drug Dzherelo\u2122 on signs of macrophage phagocyte system among teenagers with acute tonsillitis of viral etiology.","volume":"61","author":"Shapovalova IO","year":"2004","unstructured":"Shapovalova IO : Influence of plant derivative drug Dzherelo\u2122 on signs of macrophage phagocyte system among teenagers with acute tonsillitis of viral etiology.Probl. Ecol. Med. Gen. Clin. Immun.61 , 135\u2013144 (2004).","journal-title":"Probl. Ecol. Med. Gen. Clin. Immun."},{"key":"e_1_3_3_3_9_1","first-page":"127","article-title":"Phytoconcentrates \u2018Dzherelo\u2122\u2018 and \u2018Lizorm\u2018 in therapy of autoimmune thyroiditis.","volume":"8","author":"Bodnar PM","year":"2002","unstructured":"Bodnar PM , Mykhal\u2018chyshynHP, ReznichenkoVM, MoshchychOP, PylypchukVS: Phytoconcentrates \u2018Dzherelo\u2122\u2018 and \u2018Lizorm\u2018 in therapy of autoimmune thyroiditis.Lik. Sprava8 , 127\u2013129 (2002).","journal-title":"Lik. Sprava"},{"key":"e_1_3_3_3_10_1","first-page":"67","article-title":"Influence of immunotherapy on effectiveness of radiation treatment of tumor on immunomodulator Dzherelo\u2122 example.","volume":"61","author":"Barabai VA","year":"2004","unstructured":"Barabai VA , GrinevichYA, ZhinchenkoVA: Influence of immunotherapy on effectiveness of radiation treatment of tumor on immunomodulator Dzherelo\u2122 example.Probl. Ecol. Med. Gen. Clin. Immun.61 , 67\u201370 (2004).","journal-title":"Probl. Ecol. Med. Gen. Clin. Immun."},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1504\/IJBT.2007.014248"},{"key":"e_1_3_3_3_12_1","first-page":"8","volume":"2","author":"Nikolaeva LG","year":"2008","unstructured":"Nikolaeva LG , PylypchukVS, Volyanskii YuL et al.: Effect of immunomodulator Dzherelo\u2122 on CD4+ T-lymphocyte counts and viral load in HIV infected patients receiving anti-retroviral therapy. Res. J. Pharmacol.2 , 8\u201312 (2008).","journal-title":"Res. J. Pharmacol."},{"key":"e_1_3_3_3_13_1","first-page":"75","article-title":"Clinical and experimental aspects rationalizing the need for immunotherapy in the treatment of patients with tuberculosis.","volume":"70","author":"Pylypchuk VS","year":"2003","unstructured":"Pylypchuk VS : Clinical and experimental aspects rationalizing the need for immunotherapy in the treatment of patients with tuberculosis.Probl. Ecol. Med. Gen. Clin. Immun.70 , 75\u201384 (2003).","journal-title":"Probl. Ecol. Med. Gen. Clin. Immun."},{"key":"e_1_3_3_3_14_1","first-page":"36","article-title":"Efficacy and safety of phytoconcentrate Dzherelo\u2122 (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy.","volume":"3","author":"Zaitzeva SI","year":"2009","unstructured":"Zaitzeva SI , MatveevaSL, GerasimovaTG et al.: Efficacy and safety of phytoconcentrate Dzherelo\u2122 (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy.Res. J. Med. Sci.3 , 36\u201341 (2009).","journal-title":"Res. J. Med. Sci."},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02760.x"},{"key":"e_1_3_3_3_16_1","first-page":"117","article-title":"Open label trial of adjuvant immunotherapy with Dzherelo\u2122, Svitanok, and Lizorm, in MDR-TB and XDR-TB as well as TB\/HIV co-infected patients receiving anti-tuberculosis therapy under DOT.","volume":"1","author":"Prihoda ND","year":"2007","unstructured":"Prihoda ND , ArjanovaOV, YurchenkoLV et al.: Open label trial of adjuvant immunotherapy with Dzherelo\u2122, Svitanok, and Lizorm, in MDR-TB and XDR-TB as well as TB\/HIV co-infected patients receiving anti-tuberculosis therapy under DOT.J. Med. Plant. Res.1 , 117\u2013122 (2007).","journal-title":"J. Med. Plant. Res."},{"key":"e_1_3_3_3_17_1","first-page":"59","article-title":"Adjuvant immunotherapy of tuberculosis in drug-resistant TB and TB\/HIV co-infected patients.","volume":"2","author":"Prihoda ND","year":"2008","unstructured":"Prihoda ND , ArjanovaOV, YurchenkoLV et al.: Adjuvant immunotherapy of tuberculosis in drug-resistant TB and TB\/HIV co-infected patients.Intl. J. Biomed. Pharm. Sci.2 , 59\u201364 (2008).","journal-title":"Intl. J. Biomed. Pharm. Sci."},{"key":"e_1_3_3_3_18_1","unstructured":"Melnik VP PanasyukOV PylypchukVS et al.: Deployment of herbal preparations Dzherelo\u2122 and Svitanok for combination therapy of pulmonary tuberculosis. Medical Institute of Ukrainian Association of People\u2018s Medicine. In: Information Bulletin of the Ministry of Health. UDK:616.24\u2013002.5\u2013085\u2013038:615.017. Kiev Ukraine (1999)."},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.01.029"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.10.009"},{"key":"e_1_3_3_3_21_1","article-title":"Adjuvant immunotherapy of extensively drug-resistant tuberculosis (XDR-TB) in Ukraine.","author":"Arjanova OV","year":"2009","unstructured":"Arjanova OV , PrihodaND, YurchenkoLV et al.: Adjuvant immunotherapy of extensively drug-resistant tuberculosis (XDR-TB) in Ukraine.Curr. Res. TB (In Press) (2009).","journal-title":"Curr. Res. TB"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20257"},{"key":"e_1_3_3_3_23_1","first-page":"1298","article-title":"Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.","volume":"12","author":"Kizza HM","year":"2005","unstructured":"Kizza HM , RodriguezB, Quinones-MateuM et al.: Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.Clin. Diagn. Lab. Immunol.12 , 1298\u20131304 (2005).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/315328"},{"key":"e_1_3_3_3_25_1","first-page":"21","article-title":"The use of immunomodulator likopid in the combined treatment pulmonary tuberculosis.","volume":"3","author":"Svistunova AS","year":"2002","unstructured":"Svistunova AS , PineginBV, SelitskaiaRP et al.: The use of immunomodulator likopid in the combined treatment pulmonary tuberculosis.Probl. Tuberk.3 , 21\u201325 (2002).","journal-title":"Probl. Tuberk."},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383232"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1573(200008)14:5<303::AID-PTR712>3.0.CO;2-N"},{"key":"e_1_3_3_3_28_1","first-page":"518","article-title":"A randomised placebo-controlled trial of the efficacy of \u03b2-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis.","volume":"1","author":"Donald PR","year":"1997","unstructured":"Donald PR , LamprechtJH, FreestoneM et al.: A randomised placebo-controlled trial of the efficacy of \u03b2-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis.Int. J. Tuberc. Lung Dis.1 , 518\u2013522 (1997).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_3_3_29_1","first-page":"208","article-title":"A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis.","volume":"7","author":"Smego RA","year":"2003","unstructured":"Smego RA , AhmedN: A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis.Int. J. Tuberc. Lung Dis.7 , 208\u2013213 (2003).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/427995"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.9.1355"},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980000000604"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69573-1"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.09.25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:05:37Z","timestamp":1715958337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.09.25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.2217\/imt.09.25"],"URL":"https:\/\/doi.org\/10.2217\/imt.09.25","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}